B7 Transfected Melanoma Cell Vaccine

**Semantic type:** Immunologic Factor|Pharmacologic Substance

**Definition:** An allogenic whole tumor cell vaccine with potential antineoplastic activity. B7 transfected melanoma cell vaccine consists of melanoma cells that have been induced to express the human leukocyte antigen (HLA) B7. Vaccination with these altered cells may elicit an anti-tumor immune response via CD8+ cytotoxic T lymphocytes (CTL). (NCI04)

**Synonyms:** - B7 Transfected Allogenic Melanoma Cell Vaccine